BUZZ - AstraZeneca reportedly offers $10 billion to acquire obesity drug maker Rhythm, causing its share price to rise

November 5 - ** AstraZeneca AZN.L shares rose 1.3% to 14,208 pence

** Reuters, citing sources, reported that AstraZeneca (link) has made an acquisition offer worth about $10 billion to obesity drugmaker Rhythm RYTM.O

** According to the report, the highest bid presented by AstraZeneca in this non-binding proposal was $134 per share, including milestone payments

** The stock has risen about 3% so far this year

(For the convenience of non-native English speakers, Reuters provides this report in several other languages using automated translation. As automated translations may be incorrect or lack necessary context, Reuters does not guarantee the accuracy of the translated text, which is provided solely for reader convenience. Reuters accepts no liability for any harm or loss arising from use of the automated translation function.)